Protara Therapeutics Stock (NASDAQ: TARA) stock price, news, charts, stock research, profile.
Open | $2.27 |
Close | $2.23 |
Volume / Avg. | 53.15K / 297.75K |
Day Range | 2.23 - 2.33 |
52 Wk Range | 1.04 - 5.24 |
Market Cap | $45.92M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | 11.43% |
Days to Cover | 7.17 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Protara Therapeutics (NASDAQ:TARA) through any online brokerage.
Other companies in Protara Therapeutics’s space includes: Kezar Life Sciences (NASDAQ:KZR), Fortress Biotech (NASDAQ:FBIO), Estrella Immunopharma (NASDAQ:ESLA), Acurx Pharmaceuticals (NASDAQ:ACXP) and OncoCyte (NASDAQ:OCX).
There is no analysis for Protara Therapeutics.
Protara Therapeutics has a consensus price target of $25.00.
The stock price for Protara Therapeutics (NASDAQ: TARA) is $2.22 last updated July 17, 2024 at 6:53 PM EDT.
There are no upcoming dividends for Protara Therapeutics.
Protara Therapeutics’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Protara Therapeutics.
Protara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.